CHRONOS-3: randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL)

Zinzani P. L., Capra M., ÖZCAN M., Lv F., Li W., Yañez E., ...More

EHA 2021, 12 December 2021, (Full Text)

  • Publication Type: Conference Paper / Full Text
  • Ankara University Affiliated: Yes